2025-05-17 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the provided data, formatted as requested.

**Stock Ticker:** UNH

**Company Name:** UnitedHealth Group Inc

**Company Overview:** UnitedHealth Group Inc. is a diversified health care company providing a wide range of health benefits and services.

**1. Performance Relative to S&P 500 (VOO)**

*   **UNH Cumulative Return:** 21.08%
*   **VOO Cumulative Return:** 84.12%
*   **Absolute Divergence (Current):** -63.0%
*   **Divergence Range:** Max: 52.3%, Min: -63.5%
*   **Relative Divergence:** 0.4

**Analysis:**

UNH has significantly underperformed the S&P 500 (VOO) over the period. The current divergence is -63.0%, which is near the minimum divergence observed. The relative divergence of 0.4 indicates that the current underperformance is at the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | 64.0%   | 56.1%   | 35.0%   | 0.1   | 179.5  |
| 2016-2018  | 55.0%   | 63.9%   | 37.0%   | 0.2   | 205.6  |
| 2017-2019  | 41.0%   | 63.9%   | 11.0%   | 0.3   | 246.7  |
| 2018-2020  | -20.0%  | 63.9%   | -45.0%  | 0.5   | 299.2  |
| 2019-2021  | 34.0%   | 60.9%   | -20.0%  | 0.6   | 434.4  |
| 2020-2022  | 28.0%   | 67.1%   | 22.0%   | 0.6   | 464.5  |
| 2021-2023  | 34.0%   | 67.7%   | 17.0%   | 0.4   | 468.2  |
| 2022-2024  | -28.0%  | 68.7%   | -45.0%  | 0.3   | 456.9  |
| 2023-2025  | -56.0%  | 75.8%   | -88.0%  | 0.2   | 264.8  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** The CAGR shows a significant decline in recent periods, with negative growth in the last two measured timeframes.
*   **MDD (Maximum Drawdown):** The MDD has generally increased, indicating higher risk of capital loss.
*   **Alpha:** Alpha is largely negative in recent periods, suggesting the stock has been underperforming relative to its risk-adjusted expected return.
*   **Beta:** Beta values are relatively low, suggesting UNH is less volatile than the overall market (S&P 500). However, recent Beta values were much higher from 2019 to 2022.
*   **Cap(B) (Market Capitalization in Billions):** Market capitalization has fluctuated and decreased recently, possibly influenced by the negative performance.

**2. Recent Price Action**

*   **Current Price:** 291.91
*   **Previous Close:** 274.35
*   **Change:** 6.4%
*   **5-Day Moving Average:** 312.88
*   **20-Day Moving Average:** 384.28
*   **60-Day Moving Average:** 468.2472

**Analysis:**

The stock price increased significantly today (6.4% change), closing at 291.91. However, the price is still below all three moving averages (5-day, 20-day, and 60-day). This suggests that while there's been a recent rebound, the stock is still in a downtrend, as it is trading well below its short-term and medium-term moving averages.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3475 (Low Risk)
*   **RSI (Relative Strength Index):** 13.9
*   **PPO (Percentage Price Oscillator):** -3.0941
*   **Recent (20-day) Relative Divergence Change:** 0.4 (Positive)
*   **Expected Return (%):** 1261.1

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment.
*   **RSI:** The RSI is extremely low (13.9), indicating the stock is heavily oversold and potentially ripe for a further rebound.
*   **PPO:** The PPO is negative (-3.0941), which supports the view that the stock is in a downtrend.
*   **Recent Relative Divergence Change:** The positive change in relative divergence indicates a short-term upward trend compared to the S&P 500.
*   **Sudden Price Increase:** The significant 6.4% price increase suggests a strong positive catalyst or reaction to recent news. This warrants further investigation to understand the underlying reason.
*   **Expected Return:** The exceptionally high expected return (1261.1%) suggests a very optimistic long-term outlook for the stock relative to the S&P 500, potentially driven by an algorithm assuming a mean-reversion from the current oversold conditions. However, this number seems unusually high and should be interpreted with extreme caution.

**4. Recent News & Significant Events**

*   **May 14, 2025:** Major business developments, regulatory changes, or market events affecting UNH.
*   **May 16, 2025:** Analysts discussing UNH's recent performance in the context of industry trends and global economic factors.
*   **May 15, 2025:** UNH's stock experiencing notable volatility due to recent news, earnings reports, or executive actions.
*   **May 17, 2025:** Market experts highlighting both risks and opportunities for UNH, advising investors to monitor news and company announcements.

**Analysis:**

The news suggests that UNH is currently experiencing significant volatility and is subject to analyst scrutiny. Investors should closely monitor upcoming news and announcements to understand the drivers of this volatility and potential future performance.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
| :--------- | :---- | :--------- |
| 2025-05-07 | 6.9   | 109.58 B$ |
| 2024-11-04 | 6.56  | 100.82 B$ |
| 2024-08-09 | 4.58  | 98.86 B$  |
| 2024-05-09 | -1.53 | 99.80 B$  |
| 2025-05-07 | -1.53 | 99.80 B$  |

**Analysis:**

The recent earnings data shows a mixed picture. The most recent EPS (6.9) is positive and higher than previous quarters. Revenue has also increased, suggesting strong business performance. However, two of the last five quarters show negative EPS (-1.53), which needs further investigation to understand the cause. It's important to examine what happened in those quarters to cause the losses.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| :----------- | :--------- | :------------ |
| 2025-03-31   | $109.58B   | 21.70%        |
| 2024-12-31   | $100.81B   | 21.14%        |
| 2024-09-30   | $100.82B   | 22.84%        |
| 2024-06-30   | $98.86B    | 22.31%        |
| 2024-03-31   | $99.80B    | 23.05%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
| :----------- | :--------- | :------ |
| 2025-03-31   | $95.04B   | 6.62%   |
| 2024-12-31   | $92.66B   | 5.98%   |
| 2024-09-30   | $94.53B   | 6.41%   |
| 2024-06-30   | $89.36B   | 4.72%   |
| 2024-03-31   | $86.69B   | -1.63%  |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been increasing over the past five quarters, indicating strong top-line growth. Profit margins are consistently high, suggesting effective cost management and pricing power.
*   **Capital and Profitability:** Equity has also been increasing, indicating strong financial health. ROE (Return on Equity) has been generally positive, except for one quarter, suggesting efficient use of shareholder equity to generate profits.

**7. Overall Analysis**

UNH has significantly underperformed the S&P 500 recently, reflected in a large negative divergence. While there was a substantial price increase today, driven perhaps by positive earnings or other catalysts, the stock is still in a downtrend. Technical indicators like RSI suggest the stock is oversold and could rebound.

The recent news indicates that the company is experiencing volatility and is under analyst scrutiny, likely related to business developments or regulatory changes.

Financially, UNH shows strong revenue growth, high profit margins, and increasing equity. Recent earnings were positive, but the presence of some loss-making quarters warrants further investigation.

**Investment Recommendation:**

Given the recent underperformance, significant volatility, and oversold condition, investors should exercise caution. The strong financial metrics and positive earnings suggest underlying strength, but the recent underperformance relative to the S&P 500 is concerning. A "hold" rating might be appropriate, with a close watch on news developments and a re-evaluation once the stock shows sustained recovery. However, the expected return is highly optimistic, but the large volatility may need more caution.
